Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Trio Pharmaceuticals and Ajinomoto Bio-Pharma Services announced a development collaboration agreement to evaluate AJICAP.
read more
Wednesday, December 11, 2013
Trevigen Inc. has been awarded $252,000 for the Small Business Innovation Research (SBIR) Phase I Contract, 261201300042C, from the National Cancer Institute and the National Institutes of Health (NIH) to develop a tumor-aligned 3D coculture system. ...
read more
Friday, February 07, 2020
AGC Biologics and Trefoil Therapeutics announce the execution of a manufacturing contract to supply their lead compound TTHX1114.
read more
Thursday, September 26, 2019
Torrent is expanding its recall for Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets to the consumer level.
read more
Wednesday, January 26, 2022
Ajinomoto Bio-Pharma Services (“Aji Bio-Pharma”), a leading global provider of bio-pharmaceutical contract development and manufacturing services, is pleased to announce that Tony O’Neill has joined Aji Bio-Pharma as Vice President of Compliance, US ...
read more
Tilray announced its wholly-owned subsidiary Tilray Portugal Unipessoal has received a standard manufacturing license and a GMP certification.
read more
Three new chemists have joined Contract Research and Development Organization Arcinova’s Active Pharmaceutical Ingredient team.
read more
TheVax Genetics Vaccine and Biotechpharma have entered into a manufacturing agreement to produce THEVAX HBV vaccine for first-in-human clinical trials.
read more
Thermo Fisher Scientific has announced a collaboration with Scinogy to develop and commercialize fit-for-purpose instrumentation and reagent systems.
read more
Tuesday, November 10, 2020
Thermo Fisher Scientific and Innoforce have signed a joint venture agreement to establish a new pharma services facility in Hangzhou, China.
read more
The company is now supporting more than 200 of these projects globally.
read more
Thermo Fisher Scientific is investing $150 million in its Pharma Services business to provide additional capacity for sterile liquid and lyophilized product development and commercial manufacturing.
read more
Friday, November 08, 2019
Thermo Fisher Scientific is investing nearly $24 million in its Inchinnan, Scotland, site.
read more
Thermo Fisher Scientific has entered into a definitive agreement to acquire a drug substance manufacturing site in Cork, Ireland, from GlaxoSmithKline.
read more
Thermo Fisher Scientific Inc. announced that it has entered into a definitive agreement to acquire The Binding Site Group (“The Binding Site”), a provider of specialty diagnostics, from a shareholder group led by European private equity firm Nordic ...
read more